ABSI - Absci Corp

5.355
-0.425   -7.937%

Share volume: 4,056,810
Last Updated: 05-12-2026
Business Services/Services – Research, Development, Testing Labs: -0.02%

PREVIOUS CLOSE
CHG
CHG%
$5.78
-0.42
-0.07%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
32%
Profitability 35%
Dept financing 22%
Liquidity 35%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-9.24%
1 Month
75.57%
3 Months
110.00%
6 Months
102.84%
1 Year
80.91%
2 Year
5.83%
Key data
Stock price
$5.36
P/E Ratio 
0.00
DAY RANGE
$5.27 - $5.75
EPS 
-$0.79
52 WEEK RANGE
$2.24 - $6.72
52 WEEK CHANGE
$84.02
MARKET CAP 
459.064 M
YIELD 
N/A
SHARES OUTSTANDING 
155.905 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
2.50
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$6,203,347
AVERAGE 30 VOLUME 
$5,410,387
Company detail
CEO: Sean McClain
Region: US
Website: absci.com
Employees: 210
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

Absci Corporation provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Absci was founded in 2011 and is headquartered in Vancouver, Washington.

Recent news